Literature DB >> 21748284

A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120.

Veera Venkata Ratnam Bandaru1, Neha Patel, Ostefame Ewaleifoh, Norman J Haughey.   

Abstract

Drug abuse in HIV-infected individuals accelerates the onset and progression of HIV-associated neurocognitive disorders (HAND). Opiates are a class of commonly abused drugs that have interactive effects with neurotoxic HIV proteins that facilitate glial dysfunction, neuronal damage and death. While the combined effects of neurotoxic HIV proteins and morphine have been extensively studied in the setting of chronic and acute morphine use, very little in known about the effects of HIV proteins during drug withdrawal. Since opiate withdrawal can induce considerable neuronal stress, we determined the effects of opiates (morphine) on brain redox balance, sphingolipid metabolism and synaptic integrity during both chronic and withdrawal conditions in non-transgenic mice (nTg), and in mice transgenic for the HIV-coat protein gp120 (gp120tg). In nTg mice, we found that chronic morphine increased brain oxidative capacity and induced synaptic damage that was largely reversed during drug withdrawal. Gp120tg mice showed a similar response to chronic morphine, but the diminished oxidative capacity and synaptic damage failed to normalize during drug withdrawal. In nTg mice, brain sphingolipid content was not affected by morphine during chronic or withdrawal conditions. In gp120tg mice there was a baseline perturbation in sphingolipid metabolism that manifest as decreased sphingomyelin with accumulations of the bioactive lipid ceramide. Sphingolipid metabolism was highly reactive to morphine in gp120tg mice. Chronic morphine increased sphingomyelin content with a consequent reduction in ceramide. During drug withdrawal, these effects reversed, and sphingomyelin levels were reduced with consequent increases of ceramide. We interpret these findings to suggest that neuronal repair during morphine withdrawal is inhibited in the setting of gp120 by mechanisms that involve sustained oxidative insult and accumulations of the highly reactive intermediate ceramide.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748284      PMCID: PMC3422763          DOI: 10.1007/s11481-011-9289-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  54 in total

1.  Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.

Authors:  Shireen Sultana; Huifen Li; Adam Puche; Odell Jones; Joseph L Bryant; Walter Royal
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

2.  Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Sunita Gupta; Jeffrey N Keller; Pamela E Knapp; Kurt F Hauser; Annadora J Bruce-Keller
Journal:  J Neurochem       Date:  2008-11-19       Impact factor: 5.372

Review 3.  Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS.

Authors:  Jonathan Pitcher; Saori Shimizu; Silvia Burbassi; Olimpia Meucci
Journal:  J Neuroimmunol       Date:  2010-06-08       Impact factor: 3.478

4.  Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice.

Authors:  Nino Tabatadze; Alena Savonenko; Hongjun Song; Veera Venkata Ratnam Bandaru; Michael Chu; Norman J Haughey
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

5.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.

Authors:  Sylvia Fitting; Ruqiang Xu; Cecilia Bull; Shreya K Buch; Nazira El-Hage; Avindra Nath; Pamela E Knapp; Kurt F Hauser
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

6.  Spinal matrix metalloproteinase-9 contributes to physical dependence on morphine in mice.

Authors:  Wen-Tao Liu; Yuan Han; Yue-Peng Liu; Angela A Song; Beth Barnes; Xue-Jun Song
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

7.  Serum sphingomyelins and ceramides are early predictors of memory impairment.

Authors:  Michelle M Mielke; Veera Venkata Ratnam Bandaru; Norman J Haughey; Peter V Rabins; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurobiol Aging       Date:  2008-05-05       Impact factor: 4.673

8.  Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Donald E Sykes; Jessica L Reynolds; B Bindukumar; Stanley F Fernandez; Ramnik Chawda; Thomas C Shanahan; Stanley A Schwartz
Journal:  J Clin Immunol       Date:  2008-06-24       Impact factor: 8.317

9.  Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.

Authors:  David Wheeler; Edward Knapp; Veera V R Bandaru; Yue Wang; David Knorr; Christophe Poirier; Mark P Mattson; Jonathan D Geiger; Norman J Haughey
Journal:  J Neurochem       Date:  2009-03-14       Impact factor: 5.372

10.  HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.

Authors:  Kurt F Hauser; Yun Kyung Hahn; Valeriya V Adjan; Shiping Zou; Shreya K Buch; Avindra Nath; Annadora J Bruce-Keller; Pamela E Knapp
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452

View more
  24 in total

1.  Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor.

Authors:  Alessia Bachis; Lee A Campbell; Kierra Jenkins; Erin Wenzel; Italo Mocchetti
Journal:  Neurotox Res       Date:  2017-08-03       Impact factor: 3.911

Review 2.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Authors:  Peilin Jia; Zhongming Zhao; Todd Hulgan; William S Bush; David C Samuels; Cinnamon S Bloss; Robert K Heaton; Ronald J Ellis; Nicholas Schork; Christina M Marra; Ann C Collier; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; David M Simpson; J Allen McCutchan; Jill S Barnholtz-Sloan; Donald R Franklin; Debralee Rosario; Scott L Letendre; Igor Grant; Asha R Kallianpur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-26       Impact factor: 3.568

4.  Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection.

Authors:  Mihyun Bae; Neha Patel; Haoxing Xu; Mingwaoh Lee; Kumiko Tominaga-Yamanaka; Avindra Nath; Jonathan Geiger; Myriam Gorospe; Mark P Mattson; Norman J Haughey
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

5.  Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.

Authors:  Lee A Campbell; Valeriya Avdoshina; Chris Day; Seung T Lim; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2015-01-23       Impact factor: 5.250

6.  Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.

Authors:  Elizabeth M Podhaizer; Shiping Zou; Sylvia Fitting; Kimberly L Samano; Nazira El-Hage; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-19       Impact factor: 4.147

7.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

8.  Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons.

Authors:  Luis B Tovar-Y-Romo; Dennis L Kolson; Veera Venkata Ratnam Bandaru; Julia L Drewes; David R Graham; Norman J Haughey
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-18       Impact factor: 4.147

Review 9.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

10.  CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120.

Authors:  Ricky Maung; Melanie M Hoefer; Ana B Sanchez; Natalia E Sejbuk; Kathryn E Medders; Maya K Desai; Irene C Catalan; Cari C Dowling; Cyrus M de Rozieres; Gwenn A Garden; Rossella Russo; Amanda J Roberts; Roy Williams; Marcus Kaul
Journal:  J Immunol       Date:  2014-07-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.